RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS

      Nuclear Medicine Theranostics: Perspective from Pakistan

      한글로보기

      https://www.riss.kr/link?id=A106054976

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Nuclear medicine has been offering diagnostic and therapeutic solution since the introduction of radioactive iodine for thyroid diseases since decades. However, the concept of theranostics has given a new found impetus to the use of pairs of radiophar...

      Nuclear medicine has been offering diagnostic and therapeutic solution since the introduction of radioactive iodine for thyroid diseases since decades. However, the concept of theranostics has given a new found impetus to the use of pairs of radiopharmaceuticals for diagnosis and treatment. Presented here is a perspective on theranostics from Pakistan.

      더보기

      참고문헌 (Reference)

      1 Hofman MS, "[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer(LuPSMA trial) : a single-centre, single-arm, phase 2 study" 19 : 825-833, 2018

      2 Riaz S, "Triage of limited versus extensive disease on F18 FDG PET/CT scan in small cell lung cancer Asia Ocean" 5 : 109-113, 2017

      3 Younis N, "Theranostics–neuroendocrine tumours" 4 (4): 1-, 2018

      4 Bodei L, "The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy(PRRNT)in neuroendocrine tumours" 40 : 800-816, 2013

      5 Gavan SP, "The economic case for precision medicine" 3 : 1-9, 2018

      6 Zaman MU, "Significantly low effective dose from 18FDG PET/CT scans using dose reducing strategies: "lesser is better"" 17 : 3465-3468, 2016

      7 Ajit S, "Rhenium 188 : the poor Man’s yttrium" 16 : 1-2, 2017

      8 Sawin CT, "Radioiodine and the treatment of hyperthyroidism : the early history" 7 : 163-176, 1997

      9 Strosberg J, "Phase 3 trial of 177Lu-dotatate for midgut neuroendocrine tumors" 376 : 125-135, 2017

      10 Atutornu J, "Personalized medicine and medical imaging : opportunities and challenges for contemporary health care" 49 : 352-359, 2018

      1 Hofman MS, "[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer(LuPSMA trial) : a single-centre, single-arm, phase 2 study" 19 : 825-833, 2018

      2 Riaz S, "Triage of limited versus extensive disease on F18 FDG PET/CT scan in small cell lung cancer Asia Ocean" 5 : 109-113, 2017

      3 Younis N, "Theranostics–neuroendocrine tumours" 4 (4): 1-, 2018

      4 Bodei L, "The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy(PRRNT)in neuroendocrine tumours" 40 : 800-816, 2013

      5 Gavan SP, "The economic case for precision medicine" 3 : 1-9, 2018

      6 Zaman MU, "Significantly low effective dose from 18FDG PET/CT scans using dose reducing strategies: "lesser is better"" 17 : 3465-3468, 2016

      7 Ajit S, "Rhenium 188 : the poor Man’s yttrium" 16 : 1-2, 2017

      8 Sawin CT, "Radioiodine and the treatment of hyperthyroidism : the early history" 7 : 163-176, 1997

      9 Strosberg J, "Phase 3 trial of 177Lu-dotatate for midgut neuroendocrine tumors" 376 : 125-135, 2017

      10 Atutornu J, "Personalized medicine and medical imaging : opportunities and challenges for contemporary health care" 49 : 352-359, 2018

      11 Kunikowska J, "Optimizing somatostatin receptor imaging in patients with neuroendocrine tumors : the impact of 99mTc-HYNICTOC SPECT/SPECT/CT versus 68Ga-DOTATATE PET/CT upon clinical management" 42 : 905-911, 2017

      12 Mittra ES, "Neuroendocrine tumor therapy : 177Lu-DOTATATE" 211 : 278-285, 2018

      13 Sharp SE, "MIBG in neuroblastoma diagnostic imaging and therapy" 36 : 258-278, 2016

      14 Memon AS, "Isolation period of 131I administered patients at NIMRA Jamshoro Pakistan" 2 : 2-5, 2017

      15 Ahmadzahehfar H, "Iodine-131-lipiodol therapy in hepatic tumours" 55 : 246-252, 2011

      16 Riaz S, "Impact and prognostic value of 18F FDG PET-CT scan in the evaluation of residual head and neck cancer-single centre experience from Pakistan" 6 : 81-83, 2017

      17 Zaman MU, "High-dose I131 therapy on outpatient basis : imperative and no more a desire" 2 : 92-97, 2012

      18 Strosberg J, "Health-related quality of life in patients with progressive midgut neuroendocrine tumors treated with 177Lu-dotatate in the phase III NETTER-1 trial" 36 : 2578-2584, 2018

      19 Handkiewicz-Junak D, "EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides" 45 : 846-859, 2018

      20 Riaz S, "Diagnostic accuracy of 18F-FDG PET-CT in the evaluation of carcinoma of unknown primary" 25 : 1-10, 2016

      21 Virgolini I, "Current status of theranostics in prostate cancer" 45 : 471-495, 2018

      22 Ajit S, "An overview of nuclear medicine and PET CT in India" 1 (1): 2017

      23 Hassan A, "18F-FDG PET-CT imaging versus bone marrow biopsy in pediatric Hodgkin’s lymphoma : a quantitative assessment of marrow uptake and novel insights into clinical implications of marrow involvement" 44 : 1198-1206, 2017

      24 Rizzieri D. Z, "(ibritumomabtiuxetan)after more than a decade of treatment experience, what have we learned" 105 : 5-17, 2016

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2016-12-26 학술지명변경 한글명 : Nuclear Medicine and Molecular Imaging -> Nuclear Medicine and Molecular Imaging
      외국어명 : 미등록 -> Nuclear Medicine and Molecular Imaging
      KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2010-03-12 학술지명변경 한글명 : 핵의학 분자영상 -> Nuclear Medicine and Molecular Imaging KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2002-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1999-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.06 0.06 0.06
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.09 0.08 0.275 0
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼